Clinical Trials Logo

Clinical Trial Summary

The purpose of this research study is to evaluate the improvement in overall shave satisfaction, the appearance of skin irritation from shaving, and the razor related inflammation of the hair follicles when using a new razor technology in a regular shaving regimen as well as a new razor technology in a shaving regimen that includes a pre-shave gel, cleansing brush and shaving gel.


Clinical Trial Description

A secondary objective is to show improvement in the satisfaction of the shaving experience, symptoms such as bumps and irritation, and quality of life (QOL), when adding the 556 Razor, or the 556 Razor with a regimen of pre-shave gel, cleansing brush, and shave gel to the shaving regimen of males with shaving skin irritation. Shaving irritation severity will be correlated to shave satisfaction. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03569956
Study type Interventional
Source Wake Forest University Health Sciences
Contact
Status Active, not recruiting
Phase N/A
Start date October 29, 2018
Completion date August 2024

See also
  Status Clinical Trial Phase
Terminated NCT04403282 - Topical Eflornithine for Pseudofolliculitis Barbae: Randomized Controlled Trial Phase 4
Completed NCT04993066 - Clinical Evaluation to Assess the Safety and Efficacy of GentleMax Pro Plus N/A
Completed NCT03043534 - Pre-Shave Gel and Brush in Pseudofolliculitis Barbae N/A
Completed NCT00176995 - Effect of 15% Eflornithine Hydrochloride Cream on African-American Males With Pseudofolliculitis Barbae Phase 2
Completed NCT00402129 - Low Fluence 1064nm Laser Hair Reduction for Pseudofolliculitis Barbae in Skin Types IV, V, VI N/A
Withdrawn NCT04220502 - Magic Shave Powder Gold's Affects on the Occurrence of Pseudofolliculitis Barbae Early Phase 1